Akili, Inc. financial data

Industry
Surgical & Medical Instruments & Apparatus
Location
71 Commercial Street, Mailbox 312, Boston, MA
Fiscal year end
December 31
Former names
Social Capital Suvretta Holdings Corp. I (to 8/12/2022)
Latest financial report
10-Q - Q1 2024 - May 14, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 680 % -26.5%
Debt-to-equity 35.1 % -85.1%
Return On Equity -74.5 % +66.3%
Return On Assets -55.1 % -229%
Operating Margin -2.89K % +90.3%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 78.5M shares +0.52%
Common Stock, Shares, Outstanding 78.7M shares +0.73%
Entity Public Float 67M USD -72.9%
Common Stock, Value, Issued 8K USD 0%
Weighted Average Number of Shares Outstanding, Basic 78.5M shares +0.57%
Weighted Average Number of Shares Outstanding, Diluted 78.5M shares +0.57%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 1.95M USD +426%
Cost of Revenue 855K USD +77.4%
Research and Development Expense 18M USD -37.1%
Operating Income (Loss) -56.2M USD +48.8%
Nonoperating Income (Expense) 7.74M USD -90.5%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -48.5M USD -617%
Income Tax Expense (Benefit) 19K USD
Net Income (Loss) Attributable to Parent -48.5M USD -69.3%
Earnings Per Share, Basic -0.61 USD/shares -104%
Earnings Per Share, Diluted -0.61 USD/shares -104%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 63.2M USD -28.1%
Cash, Cash Equivalents, and Short-term Investments 63.2M USD -46.2%
Accounts Receivable, after Allowance for Credit Loss, Current 144K USD +194%
Other Assets, Current 1.27M USD -35.9%
Assets, Current 65M USD -46.4%
Property, Plant and Equipment, Net 835K USD -1.07%
Operating Lease, Right-of-Use Asset 1.44M USD -40.6%
Assets 67.4M USD -45.9%
Accounts Payable, Current 1.1M USD -22.1%
Accrued Liabilities, Current 1.79M USD -36.6%
Liabilities, Current 11.2M USD -1.82%
Operating Lease, Liability, Noncurrent 1.53M USD -33.8%
Other Liabilities, Noncurrent 23K USD
Liabilities 17.2M USD -46.6%
Accumulated Other Comprehensive Income (Loss), Net of Tax -25K USD
Retained Earnings (Accumulated Deficit) -310M USD -18.6%
Stockholders' Equity Attributable to Parent 50.2M USD -45.7%
Liabilities and Equity 67.4M USD -45.9%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -10M USD +47.7%
Net Cash Provided by (Used in) Financing Activities -1.89M USD -4096%
Net Cash Provided by (Used in) Investing Activities -230K USD -100%
Common Stock, Shares Authorized 1B shares 0%
Common Stock, Shares, Issued 78.7M shares +0.73%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 145K USD -35.1%
Interest Paid, Excluding Capitalized Interest, Operating Activities 310K USD -26.5%
Deferred Tax Assets, Valuation Allowance 90.4M USD +22.1%
Cash and Cash Equivalents, Period Increase (Decrease) -358K USD
Deferred Tax Assets, Gross 91.3M USD +21.3%
Operating Lease, Liability 2.49M USD -24.9%
Payments to Acquire Property, Plant, and Equipment 3K USD 0%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -48.5M USD -617%
Lessee, Operating Lease, Liability, to be Paid 2.77M USD -27.4%
Property, Plant and Equipment, Gross 1.87M USD -12.2%
Operating Lease, Liability, Current 779K USD -3.71%
Lessee, Operating Lease, Liability, to be Paid, Year Two 950K USD +3.94%
Lessee, Operating Lease, Liability, to be Paid, Year One 914K USD -12.4%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 282K USD -43.6%
Lessee, Operating Lease, Liability, to be Paid, Year Three 904K USD -4.84%
Deferred Tax Assets, Operating Loss Carryforwards 67.5M USD +21.9%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5M shares 0%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 904K USD 0%
Additional Paid in Capital 360M USD +1.79%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 75K USD -2.6%
Deferred Tax Assets, Net of Valuation Allowance 901K USD -28.4%
Share-based Payment Arrangement, Expense 5.35M USD -46.5%
Interest Expense 2.19M USD +13.4%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%